FBXL5 and colonic neoplasm: Therefore, we have selected FBXL5 gene, which showed over three folds decrease upon AM404 treatment (Figure 5B–F), functioned as an oncogene in the progression of colon cancer through regulating PTEN/PI3K/AKT signalling [24] and HIF-1α transcriptional activity [26].